Holocene Advisors

Holocene Advisors’s Medifast MED Stock Holding History

Holocene Advisors’s Portfolio MED Stock Details MED Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q2	–	Sell	-5,626	Closed	-$583K	–	806
2023 Q1	$583K	Sell	5,626 -7,602	-57%	-$842K	﹤0.01%	637
2022 Q4	$1.53M	Buy	13,228 +455	+4%	+$53K	0.01%	487
2022 Q3	$1.38M	Sell	12,773 -462	-3%	-$66.2K	0.01%	538
2022 Q2	$2.39M	Buy	13,235 +4,727	+56%	+$846K	0.01%	491
2022 Q1	$1.45M	Buy	8,508 +3,359	+65%	+$633K	0.01%	608
2021 Q4	$1.08M	Buy	+5,149	New	+$1.06M	0.01%	667
2020 Q3	–	Sell	-4,543	Closed	-$630K	–	749
2020 Q2	$630K	Buy	+4,543	New	+$417K	0.01%	492
2019 Q1	–	Sell	-1,923	Closed	-$240K	–	737
2018 Q4	$240K	Buy	+1,923	New	+$329K	﹤0.01%	597

Other funds holding MED

BlackRock New York $5.7T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Renaissance Technologies

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Dimensional Fund Advisors

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Pacer Advisors Malvern, Pennsylvania $34.9B AUM 18.19% 1-Year Est. Return

Geode Capital Management

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Bank of New York Mellon

Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

Citadel Advisors

Citadel Advisors Miami, Florida $141B AUM 30.34% 1-Year Est. Return